REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
11/01/2025
Back to search
Official data from USPTO
EXCELLA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
42
Latest update
11/02/2025
Classification
Registered
Trademark type
Word
Nice classes
1
Filing date
04/29/2014
Registration date
11/01/2016
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/13/2023
Last transaction
11/02/2025
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2015-01-00
First use in commerce
2015-01-00
Drawing code
4
Owner type
03
Owner location
BEVERLY, MA
Examiner
CROWLEY, PAUL
Law office
M30
Current location
TMO LAW OFFICE 112
Holders and representatives
Holders
QIAGEN BEVERLY, INC.
Quanta BioSciences, Inc.
Representatives
Victoria Friedman Dennemeyer & Associates, LLC
Technical classification
Nice Classes
Class 1
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Polymerase chain reaction (PCR) reagents for scientific research purposes; reagents for amplification and detection of nucleic acids for scientific research purposes; reagents for real-time and quantitative amplification and detection of nucleic acids for scientific research purposes; synthesized complementary DNA (cDNA) for scientific research purposes; reagents for amplification and detection of ribonucleic acid (RNA) for scientific research purposes; reagents for conversion of RNA into cDNA for scientific research purposes; polymerase chain reaction (PCR) reagents for medical research purposes; reagents for amplification and detection of nucleic acids for medical research purposes; reagents for real-time and quantitative amplification and detection of nucleic acids for medical research purposes; synthesized complementary DNA (cDNA) for medical research purposes; all of the foregoing not being tissue stains, hematoxylin, eosin or bluing and not being for use in anatomical pathology
Publications
History of USPTO decisions and trademark events.
42 publications found
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
04/13/2023
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
04/13/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/13/2023
E815
TEAS SECTION 8 & 15 RECEIVED
10/04/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
11/01/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/23/2019
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
06/14/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
11/01/2016
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
09/29/2016
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
09/28/2016
SUPC
STATEMENT OF USE PROCESSING COMPLETE
09/12/2016
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
09/09/2016
IUAF
USE AMENDMENT FILED
08/17/2016
EISU
TEAS STATEMENT OF USE RECEIVED
08/17/2016
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
02/23/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/29/2015
PUBO
PUBLISHED FOR OPPOSITION
12/29/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/09/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/03/2015
XAEC
EXAMINER'S AMENDMENT ENTERED
11/03/2015
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/03/2015
GNEA
EXAMINERS AMENDMENT E-MAILED
11/03/2015
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/03/2015
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
08/14/2015
GNFR
FINAL REFUSAL E-MAILED
08/14/2015
CNFR
FINAL REFUSAL WRITTEN
08/14/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/22/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/21/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/21/2015
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/27/2015
GNRT
NON-FINAL ACTION E-MAILED
02/27/2015
CNRT
NON-FINAL ACTION WRITTEN
02/27/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/06/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/05/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/05/2015
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/18/2014
GNRT
NON-FINAL ACTION E-MAILED
08/18/2014
CNRT
NON-FINAL ACTION WRITTEN
08/18/2014
DOCK
ASSIGNED TO EXAMINER
08/12/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/13/2014
NWAP
NEW APPLICATION ENTERED
05/02/2014
Continuous trademark protection
Get notified about every new filing that threatens EXCELLA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.